• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[勘误] miR-593通过靶向与SLUG相关的信号通路抑制非小细胞肺癌细胞的增殖和侵袭并促进其凋亡。

[Corrigendum] miR‑593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways.

作者信息

Wei Fang, Wang Mofei, Li Zhen, Wang Yong, Zhou Yong

机构信息

Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning 110033, P.R. China.

出版信息

Mol Med Rep. 2022 Feb;25(2). doi: 10.3892/mmr.2021.12555. Epub 2021 Dec 8.

DOI:10.3892/mmr.2021.12555
PMID:34878153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8674713/
Abstract

Subsequently to the publication of this paper, an interested reader drew to the authors' attention that Fig. 5D on p. 5180 appeared to contain a pair of data panels with overlapping data comparing between the H1299/NC and H1299/Mimic experiments, such that these data panels may have been derived from the same original source. The authors have consulted their original data, and realized that one of the images was inadvertently selected inappropriately for the figure. Nevertheless, they were able to present all the original data to the Editorial Office, and the repeated experiments revealed the same trends in terms of significant differences in cell migration and invasion. The corrected version of Fig. 5, showing all the correct data for Fig. 5D, is shown on the next page. Note that the errors in Fig. 5 did not significantly affect the results or the conclusions reported in this paper, and all the authors agree to this Corrigendum. The authors are grateful to the Editor of for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused. [the original article was published in 20: 5172‑5182, 2019; DOI: 10.3892/mmr.2019.10776].

摘要

在本文发表之后,一位感兴趣的读者提请作者注意,第5180页的图5D似乎包含一对数据面板,其中比较H1299/NC和H1299/Mimic实验的数据存在重叠,因此这些数据面板可能来自同一原始来源。作者查阅了原始数据,意识到其中一张图片在无意中被不恰当地选入了该图。尽管如此,他们能够向编辑部提供所有原始数据,并且重复实验在细胞迁移和侵袭的显著差异方面显示出相同的趋势。图5的校正版本在下一页,展示了图5D的所有正确数据。请注意,图5中的错误并未对本文报告的结果或结论产生显著影响,所有作者均同意此勘误。作者感谢《》的编辑给予他们发表此勘误的机会,并就由此给读者带来的不便表示歉意。[原文章发表于《》2019年第20卷:5172 - 5182页;DOI: 10.3892/mmr.2019.10776]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06c/8674713/87b124037c19/mmr-25-02-12555-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06c/8674713/87b124037c19/mmr-25-02-12555-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06c/8674713/87b124037c19/mmr-25-02-12555-g00.jpg

相似文献

1
[Corrigendum] miR‑593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways.[勘误] miR-593通过靶向与SLUG相关的信号通路抑制非小细胞肺癌细胞的增殖和侵袭并促进其凋亡。
Mol Med Rep. 2022 Feb;25(2). doi: 10.3892/mmr.2021.12555. Epub 2021 Dec 8.
2
[Corrigedum] miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling.[勘误] miR-185通过靶向SOX9和调节Wnt信号通路抑制非小细胞肺癌细胞的增殖和侵袭。
Mol Med Rep. 2023 May;27(5). doi: 10.3892/mmr.2023.12984. Epub 2023 Mar 24.
3
[Corrigendum] microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.[勘误] 微小RNA-181a-5p在肾细胞癌中起癌基因作用。
Mol Med Rep. 2024 Apr;29(4). doi: 10.3892/mmr.2024.13182. Epub 2024 Feb 16.
4
[Corrigendum] Downregulation of miR‑637 promotes proliferation and metastasis by targeting Smad3 in keloids.[勘误] miR-637的下调通过靶向瘢痕疙瘩中的Smad3促进增殖和转移。
Mol Med Rep. 2023 Oct;28(4). doi: 10.3892/mmr.2023.13083. Epub 2023 Sep 8.
5
[Corrigendum] MicroRNA‑378 enhances migration and invasion in cervical cancer by directly targeting autophagy‑related protein 12.[勘误] 微小RNA-378通过直接靶向自噬相关蛋白12增强宫颈癌的迁移和侵袭能力。
Mol Med Rep. 2025 Jan;31(1). doi: 10.3892/mmr.2024.13366. Epub 2024 Oct 18.
6
[Corrigendum] miR‑647 and miR‑1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer.[勘误] miR-647和miR-1914通过下调结直肠癌中的核因子IX同等程度地促进癌症进展。
Mol Med Rep. 2022 Jun;25(6). doi: 10.3892/mmr.2022.12713. Epub 2022 Apr 21.
7
[Corrigendum] miR‑200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non‑small cell lung cancer cells.[勘误] miR-200b/c靶向RhoE的表达并抑制非小细胞肺癌细胞的增殖和侵袭。
Int J Oncol. 2022 Dec;61(6). doi: 10.3892/ijo.2022.5432. Epub 2022 Oct 5.
8
[Corrigendum] Overexpression of septin‑7 inhibits melatonin‑induced cell apoptosis in human fetal osteoblastic cells via suppression of endoplasmic reticulum stress.[勘误] Septin-7的过表达通过抑制内质网应激来抑制褪黑素诱导的人胎儿成骨细胞凋亡。
Mol Med Rep. 2022 Jan;25(1). doi: 10.3892/mmr.2021.12538. Epub 2021 Nov 23.
9
[Corrigendum] Altered expression of miR‑152 and miR‑148a in ovarian cancer is related to cell proliferation.[勘误] 卵巢癌中miR-152和miR-148a表达的改变与细胞增殖有关。
Oncol Rep. 2022 Apr;47(4). doi: 10.3892/or.2022.8285. Epub 2022 Feb 16.
10
[Corrigendum] MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.[勘误] 微小RNA-148a通过直接靶向WNT-1抑制乳腺癌的迁移和侵袭。
Oncol Rep. 2022 Jun;47(6). doi: 10.3892/or.2022.8317. Epub 2022 Apr 13.

引用本文的文献

1
The role of HOXA1 in cancer and targeted therapy.HOXA1在癌症及靶向治疗中的作用。
Med Oncol. 2025 Aug 4;42(9):405. doi: 10.1007/s12032-025-02980-2.
2
Comprehensive analysis of the LINC01122/TPD52 axis as a predictive biomarker in prostate adenocarcinoma.LINC01122/TPD52轴作为前列腺腺癌预测生物标志物的综合分析
Sci Rep. 2025 May 8;15(1):16122. doi: 10.1038/s41598-025-98219-1.
3
Influence of the lncRNA SLC9A3-AS1 on colon cancer and the biological activities of colon cancer cells.长链非编码RNA SLC9A3-AS1对结肠癌及结肠癌细胞生物学活性的影响
Discov Oncol. 2025 Mar 19;16(1):358. doi: 10.1007/s12672-025-02134-w.
4
Erythronecroptosis: an overview of necroptosis or programmed necrosis in red blood cells.红细胞红细胞凋亡:细胞程序性坏死或红细胞凋亡概述。
Mol Cell Biochem. 2024 Dec;479(12):3273-3291. doi: 10.1007/s11010-024-04948-8. Epub 2024 Mar 1.